Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial-Reference-Cited by-同舟云学术

Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial

Published:2016-11 Issue:11 Volume:17 Page:1509-1520
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Sun Ying,Li Wen-Fei,Chen Nian-Yong,Zhang Ning,Hu Guo-Qing,Xie Fang-Yun,Sun Yan,Chen Xiao-Zhong,Li Jin-Gao,Zhu Xiao-Dong,Hu Chao-Su,Xu Xiang-Ying,Chen Yuan-Yuan,Hu Wei-Han,Guo Ling,Mo Hao-Yuan,Chen Lei,Mao Yan-Ping,Sun Rui,Ai Ping,Liang Shao-Bo,Long Guo-Xian,Zheng Bao-Min,Feng Xing-Lai,Gong Xiao-Chang,Li Ling,Shen Chun-Ying,Xu Jian-Yu,Guo Ying,Chen Yu-Ming,Zhang Fan,Lin Li,Tang Ling-Long,Liu Meng-Zhong,Ma Jun

Publisher

Elsevier BV

Subject

Oncology

Reference34 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging;Mao;Int J Radiat Oncol Biol Phys,2009

3. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?;Lai;Int J Radiat Oncol Biol Phys,2011

4. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial;Chen;Lancet Oncol,2012

Cited by 725 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of immunochemotherapy followed by surgery or chemoradiotherapy in locally advanced esophageal squamous cell cancer;International Immunopharmacology;2024-11

2. Induction plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy in elderly patients with locoregionally advanced nasopharyngeal carcinoma;Radiotherapy and Oncology;2024-11

3. Delta magnetic resonance imaging radiomics features‑based nomogram predicts long‑term efficacy after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma;Oral Oncology;2024-10

4. Tislelizumab plus neoadjuvant chemotherapy and concurrent chemoradiotherapy versus neoadjuvant chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A retrospective study;Translational Oncology;2024-10

5. Maintenance treatment with oral anticancer agents after first-line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis;European Archives of Oto-Rhino-Laryngology;2024-08-28